TELA Bio Inc. (TELA)
2.28
-0.06 (-2.56%)
At close: Mar 04, 2025, 9:40 AM
TELA Bio Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -46.66M | -44.3M | -33.28M | -28.79M | -22.43M | -21.09M | -21.33M |
| Depreciation & Amortization | 808K | 1.19M | 535K | 525K | 582K | 1.25M | 761K |
| Stock-Based Compensation | 5.03M | 3.99M | 3.66M | 2.06M | 457K | 216K | 197K |
| Other Working Capital | 4.1M | 3.62M | 1.68M | 2.39M | -2.1M | -1.07M | 1.53M |
| Other Non-Cash Items | 1.64M | 4.13M | 2.1M | 1.84M | 2.09M | 2.94M | 3.97M |
| Deferred Income Tax | n/a | n/a | 14K | n/a | 5K | 1.22M | -40K |
| Change in Working Capital | -1.67M | -5.76M | -3.47M | -86K | -6.24M | -4.46M | 75K |
| Operating Cash Flow | -40.86M | -40.75M | -30.43M | -24.46M | -25.52M | -19.92M | -16.37M |
| Capital Expenditures | -611K | -1.87M | -627K | -167K | -2.7M | -1.56M | -114K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | 4K | 13K |
| Purchase of Investments | n/a | -1M | n/a | n/a | -9.28M | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | 9.29M | n/a | n/a | n/a |
| Other Investing Acitivies | 12K | 1M | n/a | 9.29M | -11.78M | 4K | 13K |
| Investing Cash Flow | -599K | -1.87M | -627K | 9.12M | -11.98M | -1.56M | -101K |
| Debt Repayment | n/a | 10M | n/a | n/a | n/a | 25M | 12.2M |
| Common Stock Repurchased | n/a | n/a | 38K | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 141K | -3.55M | 585K | -313K | 14.38M | 2.41M | 28.87M |
| Financial Cash Flow | 46.27M | 40.85M | 585K | 44.41M | 65.53M | 27.41M | 26.34M |
| Net Cash Flow | 4.97M | -1.91M | -30.46M | 29.09M | 28.02M | 5.93M | 9.87M |
| Free Cash Flow | -41.47M | -42.62M | -31.06M | -24.62M | -28.22M | -21.49M | -16.48M |